At Avid, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. Through the use of our targeted molecular imaging agents we seek to provide physicians with the tools to detect the first stages of pathological change, allowing early treatment and management of people at risk.
